Prevalência de infecções relacionadas a assistência à saúde em uma unidade de terapia intensiva de um hospital escola no oeste do Paraná

• Autor(a) principal: Teixeira, Maycon Gabriel Duarte
• Data de Publicação: 2023
• Outros Autores: Silva, Claudinei Mesquita da, Peder, Leyde Daiane de
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/41429
• topic: Intensive Care Units; Prevalence; Nosocomial infection; Drug resistance.; Unidades de Cuidados Intensivos; Prevalencia; Infección nosocomial; Resistencia a medicamentos.; Unidades de Terapia Intensiva; Prevalência; Infecção nosocomial; Resistência a medicamentos.

Introduction: Healthcare-associated infection (HAI), considered a nosocomial infection, is a concerning event for global public health, due to its high level of morbidity and mortality. Objective: To identify the main bacteria that cause infection in an Intensive Care Unit (ICU) and their sensitivity profiles. Methodology: Retrospective observational cross-sectional study, carried out in patients admitted to the ICU of a Teaching Hospital in the city of Cascavel - PR, in the year 2021. Results: Most patients were male (70.96%) and the microorganisms were isolated mainly from tracheal secretion 92 (49.46%). Of the total of 186 patients admitted to the ICU, 120 (64.51%) had co-infection with SARS-CoV-2, and of these, 78 (42.29%) died. Of the total of 22 species of bacteria isolated, there was a higher prevalence of Pseudomonas aeruginosa (20.22%), followed by Klebsiella pneumoniae (15.73%) and Staphylococcus aureus (9.55%). Regarding antimicrobial resistance, Pseudomonas aeruginosa showed an average of 65.37% resistance to the drugs tested, followed by Klebsiella pneumoniae (58.45%) and Staphylococcus aureus (37.05%). Conclusion: Pseudomonas aeruginosa was the main bacteria isolated, showing high resistance to drugs from the quinolones, penicillins, cephalosporins, nitrofurans and sulfonamides classes, reaching up to 100% resistance to some antimicrobials tested.